You cannot buy Anthropic shares through a UK brokerage account today.
As of 28 August 2026, Anthropic is privately held. It has not completed an initial public offering, so there's no ticker, no exchange listing, and no share price in dollars or pounds.
Anthropic confidentially submitted a draft registration statement (Form S-1) to the US Securities and Exchange Commission on 1 June 2026. Investors reportedly expect a listing as soon as October 2026, but neither the date nor the terms are confirmed.
This page covers what UK investors specifically need to know: how you'll actually buy the shares from the UK, whether they can go in a Stocks and Shares ISA, what it costs to convert pounds into dollars to buy them, and which UK brokers currently support US shares at all.
| Anthropic IPO status | Detail |
|---|---|
| Listed on a stock exchange? | No. Privately held |
| Draft S-1 filed? | Yes, confidentially, 1 June 2026 |
| Reported lead underwriters | Morgan Stanley, Goldman Sachs (Bloomberg reported both around 3 June 2026; some reports add JPMorgan) |
| Reported listing target | October 2026. Reported by the Financial Times (13 Aug 2026) as investors' expectation, not confirmed by Anthropic |
| Reported IPO valuation target | $2 trillion or more (about £1.48 trillion at the GBP/USD rate on 2 September 2026) |
| Latest confirmed private valuation | $965 billion post-money (about £715 billion), after a $65 billion Series H round Anthropic announced on 28 May 2026 |
| Exchange | Not announced. Almost certainly NYSE or Nasdaq given comparable US tech listings |
| Ticker symbol | Not announced |
| Share price | Does not exist yet, in dollars or pounds |
| Stocks and Shares ISA eligible once listed? | Should qualify, since NYSE and Nasdaq are both on HMRC's recognised stock exchange list, the same basis on which UK investors already hold US shares like Apple or Amazon in an ISA. Confirm with your broker once Anthropic actually lists |
Best UK brokers to buy Anthropic shares
No broker currently offers Anthropic shares, because Anthropic isn't listed. Any UK trading platform, app, or "pre-IPO" offer claiming otherwise should be treated with real suspicion (see the pre-IPO section below).
What you can do now is make sure your UK brokerage account will actually be able to buy Anthropic shares the moment it lists.
For UK investors specifically, that comes down to four things:
- Whether the broker gives you access to the exchange Anthropic lists on (NYSE or Nasdaq)
- Whether it's regulated by the Financial Conduct Authority (FCA), so your money is covered by the Financial Services Compensation Scheme (FSCS) up to £85,000 per person, per firm, for investments
- Whether it lets you hold US shares inside a Stocks and Shares ISA, so any gain is free of Capital Gains Tax and Dividend Tax
- What it charges to convert your pounds into dollars, since Anthropic will price and trade in USD
| Broker | FCA regulated? | Real share ownership or CFD only? | Stocks and Shares ISA? | Typical FX conversion fee |
|---|---|---|---|---|
| eToro | Yes, eToro (UK) Ltd | Real ownership on its share-dealing account | Yes. eToro removed ISA fees and now runs a 0% commission Stocks and Shares ISA (as of 29 July 2026) | 0.75% FX conversion fee on stock trades |
| IG | Yes | Real ownership via its share dealing account | Yes, IG offers a Stocks and Shares ISA | 0.49% currency conversion fee on top of the exchange rate |
| XTB | Yes | Real ownership | Yes, XTB launched a zero-fee Stocks and Shares ISA for the UK market in 2026 | XTB 0% commission up to €100,000 monthly turnover then 0.2% (min €10), plus a 0.5% FX margin |
Supporting US shares in general doesn't guarantee same-day access to any one new listing, Anthropic included, so this table shows which brokers can plausibly offer it based on their existing US share access, not a confirmation that any of them will on day one.
How do UK investors buy Anthropic shares?
You buy Anthropic shares the same way you'd buy any other newly listed US company's shares from the UK: through a broker with access to the exchange it lists on, once trading has actually begun, converting pounds to dollars along the way.
That's not possible today because Anthropic hasn't listed. Once it does, the process will look like this:
- Open or fund a UK share dealing account (or Stocks and Shares ISA, if you want any gains sheltered from tax) with a broker that offers access to US-listed shares.
- Complete identity verification, standard for any FCA-regulated broker.
- Fund the account in GBP, then convert to USD either automatically at the point of trade or manually in advance, depending on the broker. Check the FX fee first; it typically runs to a small percentage of the converted amount and is one of the main real costs of buying a US stock from the UK.
- Wait for the shares to actually begin trading. Most retail investors cannot buy at the IPO offer price. Shares become available on the open market once trading opens, often at a different price than the offer price.
- Search for Anthropic's ticker symbol in your broker's platform once it's confirmed and live.
- Choose an order type. A market order buys at the current price immediately. A limit order lets you cap the price you'll pay, generally the safer choice on a stock's volatile first trading days.
- Decide on position size, bearing in mind newly listed, high-valuation tech IPOs are typically far more volatile than established stocks in their first weeks and months.
- Place the order and confirm the trade.
- Check whether the shares qualify for your ISA if that matters to you, and whether your broker actually supports holding them there, since not every broker's ISA covers every US stock automatically.
- Monitor your position and any lock-up expiry dates, since large blocks of insider shares becoming sellable can add downward price pressure at those points.
There's no UK stamp duty to budget for here. Stamp Duty Reserve Tax at 0.5% applies to UK-incorporated shares; it does not apply to US-listed shares like Anthropic's, so that's one cost that's lower than buying a UK stock, even before the FX fee is weighed in.
Can you buy Anthropic shares today?
No. As of 28 August 2026, you cannot buy Anthropic shares today through any legitimate UK investment platform or brokerage. Anthropic has not completed an IPO and no shares trade on any exchange, in London, New York, or anywhere else.
Anthropic has also explicitly warned that unauthorised platforms claiming to sell its private shares to retail buyers are not offering anything legitimate. The company states plainly:
"Any sale or transfer of Anthropic stock, or any interest in Anthropic stock, that has not been approved by our Board of Directors is void and will not be recognized on our books and records."
There's a UK-specific angle worth knowing here too. Firms that promote unlisted investment vehicles like SPVs to ordinary UK retail investors, without the right permissions or client categorisation, can fall foul of FCA financial promotion rules on top of Anthropic's own transfer restrictions. Two separate reasons the same offer is worth avoiding.
The only current option for UK retail investors is indirect exposure through public companies or funds that hold a stake in Anthropic, covered below. That is not the same as owning Anthropic shares.
When is the Anthropic IPO?
There is no confirmed IPO date.
What's confirmed: Anthropic confidentially submitted a draft S-1 registration statement to the SEC on 1 June 2026. This is a standard early step that gives the company "optionality to proceed with going public" pending SEC review, without committing to a timeline.
What's reported but not confirmed:
- The Financial Times reported on 13 August 2026, citing Anthropic investors, that the company is expected to go public in October 2026 at a valuation of $2 trillion or more. If accurate, that would make it the largest IPO in history, US or otherwise.
- Bloomberg separately reported around 3 June 2026 that Anthropic had selected Morgan Stanley and Goldman Sachs to lead the offering.
- CNBC reported on 21 August 2026 that the eventual public filing is expected to list "AI backlash" among Anthropic's risk factors.
None of this is a confirmed date. Treat "October 2026" as a reported target, not a fact, until Anthropic files a public S-1 or announces pricing. Because Anthropic will list on a US exchange, UK investors won't get any earlier or later access than US ones; the timing is identical, only the currency conversion and account type differ.
What will Anthropic's share ticker be?
Anthropic has not confirmed a ticker symbol, and none should be assumed or advertised as official, including any ticker shown on price-comparison or "trade now" style pages elsewhere online.
The ticker will typically be announced when Anthropic files a public, non-confidential S-1, or in the days before its shares begin trading. This page will be updated the moment it's confirmed.
How can UK investors buy Anthropic IPO shares before trading begins?
There's a real difference between getting an IPO allocation and buying shares once they begin public trading. It matters because most retail investors, in the UK or anywhere else, only have access to the second.
An IPO allocation means buying shares directly from the company or its underwriters at the fixed IPO offer price, before the stock opens for public trading. This is typically reserved for:
- Institutional investors
- The underwriting banks' large clients
- Occasionally, retail customers of a broker with a specific allocation arrangement with the underwriters
UK retail investors are very rarely offered a slice of a US mega-cap IPO allocation directly. It is not guaranteed to anyone, and demand for a listing as high-profile as Anthropic's is likely to far outstrip the shares available at the offer price.
Buying once public trading begins simply means placing a normal buy order on the open market after the stock lists, through any UK broker with access to the listing exchange. The price at that point may already be well above, or below, the IPO offer price.
If you want a shot at an allocation, the practical step is holding an account with a broker that has historically offered any form of IPO access to retail clients, then watching for an Anthropic-specific allocation announcement close to the listing. Go in assuming you will most likely end up buying on the open market instead, converting GBP to USD as part of that trade.
How can you buy Anthropic shares pre-IPO?
Anthropic has unusually strict restrictions on transferring its private shares. UK investors should treat almost any "buy Anthropic shares pre-IPO" offer with real caution, for the same underlying reasons as investors anywhere else.
Anthropic's own policy, published on its Help Center, states: "Any sale or transfer of Anthropic stock, or any interest in Anthropic stock, that has not been approved by our Board of Directors is void and will not be recognized on our books and records."
That means an unapproved purchase can leave a buyer with no actual legal claim to any shares, wherever in the world they're based.
Anthropic has also said explicitly: "We do not permit special purpose vehicles (SPVs) to acquire Anthropic stock and any transfer of shares to an SPV are void under our transfer restrictions."
SPVs are the pooled-investment structure most retail-facing "pre-IPO access" platforms use to let smaller investors buy into private companies.
In May 2026, Anthropic publicly named several platforms as unauthorised to sell or facilitate transfers of its stock:
- Unicorns Exchange
- Open Doors Partners
- Pachamama Capital
- Lionheart Ventures
- Hiive
- Forge Global
- Sydecar
- Upmarket
Anthropic also warned that tokenised or "forward contract" products referencing Anthropic shares may have no legal value.
In short: legitimate direct ownership of pre-IPO Anthropic stock is essentially closed to retail investors everywhere, the UK included. It's a small, board-approved circle even among existing shareholders and employees.
Can UK investors get indirect exposure to Anthropic?
Yes, but only through public companies or funds that hold a stake in Anthropic. That's meaningfully different from owning Anthropic shares directly, since your return depends on the whole rest of that company's or fund's business too, not just Anthropic's performance.
Three verifiable options as of August 2026, all buyable from a UK brokerage account that offers US shares:
| Vehicle | Anthropic exposure | Notes for UK investors |
|---|---|---|
| Amazon (NASDAQ: AMZN) | Billions invested since 2023 via convertible notes and nonvoting preferred stock; position carried well over $70 billion in value as of a June 2026 Fortune report | Buyable via any UK broker offering US shares; no voting control or operating stake in Anthropic's business |
| Alphabet (NASDAQ: GOOGL) | Roughly $50 billion cumulative commitment as of April 2026; straight equity stake reported at roughly 14%, contractually capped at 15% | Same access route as Amazon; reported by Fortune, June 2026 |
| Destiny Tech100 (NYSE: DXYZ) | Added Anthropic exposure among roughly $127 million of new positions, disclosed in its Q4 2025 results (reported 11 February 2026) | A US-listed closed-end fund. Check with your specific UK broker whether it's tradeable and, separately, whether HMRC's PRIIPs/KID documentation requirements affect its availability on that platform, since some UK brokers restrict US-domiciled funds for retail clients |
None of these gives you Anthropic shares, dividends tied to Anthropic specifically, or a direct claim on Anthropic's equity. You're buying Amazon, Alphabet, or a diversified private-tech fund, with Anthropic as one input among many into that company's or fund's overall value.
What does Anthropic do?
Anthropic is an AI safety and research company, structured as a US Public Benefit Corporation.
It was founded in 2021 by siblings Dario Amodei and Daniela Amodei, along with several former OpenAI colleagues.
It's best known for Claude, its family of large language models, including the Opus, Sonnet, and Haiku tiers. Anthropic positions Claude as a leading alternative to OpenAI's ChatGPT and Google's Gemini for both consumer and enterprise use.
Commercially, Anthropic's growth has been driven heavily by developer and enterprise products: an API platform used to build AI-powered applications, Claude Code for software development, and enterprise deployments across finance, healthcare, and government.
Claude is available through all three major cloud platforms: Amazon Web Services, Google Cloud, and Microsoft Azure. That's helped fuel rapid revenue growth even before any public listing.
What is Anthropic worth?
Anthropic's latest confirmed valuation is $965 billion, about £715 billion at the GBP/USD rate on 2 September 2026.
That figure was set when the company closed a $65 billion Series H funding round, announced 28 May 2026, led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital. It's a private financing valuation, agreed between Anthropic and its investors.
It is not a public market valuation and doesn't reflect what public investors, in London or New York, would actually pay for the stock.
Separately, the Financial Times reported on 13 August 2026 that Anthropic investors expect an eventual IPO valuation of $2 trillion or more, roughly double the Series H figure.
That's a reported expectation ahead of pricing, not a confirmed valuation. The actual IPO price, if and when it happens, could land meaningfully above or below it, and so could the GBP conversion by the time it's confirmed.
How much will Anthropic shares cost?
There is no public share price for Anthropic, in dollars or pounds. None exists until the company completes an IPO and shares actually begin trading.
Any "price" you see quoted for Anthropic shares today, in USD or GBP, is not a real, tradable market price.
Once Anthropic files a public S-1 and sets a price range ahead of its roadshow, then prices the offering the night before trading begins, this page will be updated with the confirmed IPO offer price in USD, an illustrative GBP conversion, and, once trading starts, the live market price.
Should UK investors buy Anthropic shares?
Whether to buy Anthropic shares, once it's actually possible, depends on factors that are true of any high-profile, high-valuation tech IPO. It doesn't depend on any special insight into Anthropic's future returns, and being a UK investor buying a US stock adds a few extra practical questions on top.
Worth weighing before you decide:
- Whether you're comfortable with the volatility typical of a newly listed stock in its first weeks and months
- Whether a reported $2 trillion-plus valuation target already prices in a large amount of future growth, leaving less room for upside if growth slows
- How much of your portfolio a single, unproven-as-public position should represent
- Whether you'd rather wait past the initial post-IPO volatility and any lock-up expiry dates, when employee and early-investor shares can be sold, before buying
- Whether you already have AI-sector exposure through other holdings, including UK and European funds with large US tech weightings, that makes concentrating further in one company less appealing
- Whether you want the position inside a Stocks and Shares ISA for the tax treatment, and whether your chosen broker's ISA actually supports it
- What the FX conversion is doing to your effective entry price, on top of the share price itself
None of this is a recommendation. It's the checklist worth working through with your own risk tolerance and time horizon before deciding.
What are the risks of investing in Anthropic?
The most significant risks are specific to Anthropic and the AI industry, not generic stock-market risk, and UK investors carry one extra layer on top: currency risk.
- Intense, well-funded competition. OpenAI, Google DeepMind, Microsoft, Meta, and xAI are all racing on the same frontier-model technology. Anthropic's lead in any given capability can be temporary.
- Extremely capital- and compute-intensive business. Anthropic is committing tens of billions of dollars to compute capacity and cloud infrastructure. Its ability to keep scaling depends heavily on continued access to chips and cloud capacity from partners including Amazon, Google, and Microsoft, who are also its major investors and, in some cases, competitors.
- Unproven public profitability. Anthropic's path to sustained, audited GAAP profitability as a public company is not yet demonstrated publicly.
- "AI backlash" as a named risk factor. CNBC reported on 21 August 2026 that this is expected to appear in Anthropic's filing, covering regulatory scrutiny, public sentiment on AI safety and job displacement, and potential restrictions on AI deployment, in the US, the UK, and the EU alike.
- Unusual governance structure. As a Public Benefit Corporation overseen in part by a Long-Term Benefit Trust, Anthropic's mission-driven governance could in principle constrain decisions that a purely shareholder-focused company would make differently.
- IPO-specific risks. These include a valuation set at the peak of AI-sector enthusiasm, likely lock-up expirations that add selling pressure in the months after listing, and the general volatility newly public, richly valued tech stocks tend to see in their first year of trading.
- Currency risk. Because Anthropic will trade in US dollars, a UK investor's return depends on both the share price and the GBP/USD exchange rate. A falling pound increases the sterling value of a US holding, and a rising pound reduces it, regardless of how the shares themselves perform.
Anthropic shares FAQs
No. As of 28 August 2026, Anthropic is a private company. It has confidentially submitted a draft S-1 to the SEC but has not listed on any exchange in the US, UK, or elsewhere.
Nowhere yet, legitimately. Once Anthropic completes its IPO, you’ll be able to buy shares through any UK brokerage account with access to the exchange it lists on, most likely NYSE or Nasdaq.
Once Anthropic actually lists, its shares should be ISA-eligible, since NYSE and Nasdaq are both recognised stock exchanges under HMRC rules, the same basis on which UK investors already hold shares like Apple or Amazon in an ISA. The annual ISA subscription limit is £20,000 for the 2026/27 tax year, across all your ISAs combined. Any gain on shares held outside an ISA is taxed under normal Capital Gains Tax rules, with a £3,000 annual exempt amount for 2026/27, and any dividends outside an ISA use the £500 dividend allowance before the dividend tax rates apply.
No. UK Stamp Duty Reserve Tax, at 0.5%, applies to UK-incorporated shares. Anthropic will be a US-incorporated company listed on a US exchange, so it falls outside UK stamp duty. You will still pay any FX conversion fee your broker charges to convert GBP into USD.
Claude is Anthropic’s product, not a separately listed company. “Claude shares” and “Anthropic shares” refer to the same thing, and neither is currently purchasable on any exchange.
Direct ownership is effectively closed to retail investors, in the UK and elsewhere, because of Anthropic’s board-approval requirement and its explicit ban on SPV-based transfers. Most “invest in Anthropic pre-IPO” offers you’ll encounter are not authorised by the company, and firms promoting them to UK retail investors without the right permissions may also be breaching UK financial promotion rules. The closest legitimate options are indirect exposure through public companies like Amazon and Alphabet, or funds like Destiny Tech100, that hold Anthropic stakes.
None has been announced. Treat any ticker you see quoted for Anthropic today as unconfirmed.
Watch for Anthropic filing a public, non-confidential S-1 with the SEC, followed by a pricing announcement typically the evening before the stock begins trading. Both would be covered by major UK and US financial media and updated on this page.